4//SEC Filing
Sofinnova Partners SAS 4
Accession 0001209191-22-046250
CIK 0001868734other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:19 PM ET
Size
6.8 KB
Accession
0001209191-22-046250
Insider Transaction Report
Form 4
Sofinnova Capital IX
10% Owner
Transactions
- Purchase
Common Stock
2022-08-15$30.00/sh+133,333$3,999,990→ 4,220,979 total(indirect: By Sofinnova Capital IX)
Sofinnova Partners SAS
10% Owner
Transactions
- Purchase
Common Stock
2022-08-15$30.00/sh+133,333$3,999,990→ 4,220,979 total(indirect: By Sofinnova Capital IX)
Footnotes (1)
- [F1]The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
IncorporatedFrance
Related Parties
1- filerCIK 0001574139
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:19 PM ET
- Size
- 6.8 KB